A Study of PD1 Combined With DC-NK Cell in the Treatment of Solid Tumors
Status:
Unknown status
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
clinical study on the safety and efficacy of PD1 combined with dc-Nk in the treatment of
solid tumors
Phase:
Early Phase 1
Details
Lead Sponsor:
Allife Medical Science and Technology Co., Ltd.
Collaborators:
Beijing Hospital Henan Provincial People's Hospital The First People's Hospital of Yunan Province/First People's Hospital of Yunan Provinve New Kunhua Hospital